참고문헌
- Chakraborty, S., Kubatzky, K.F., and Mitra, D.K. (2019). An update on interleukin-9: from its cellular source and signal transduction to its role in immunopathogenesis. Int. J. Mol. Sci. 20, e2113. https://doi.org/10.3390/ijms20092113
- Chang, H.C., Sehra, S., Goswami, R., Yao, W., Yu, Q., Stritesky, G.L., Jabeen, R., McKinley, C., Ahyi, A.N., Han, L., et al. (2010). The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation. Nat. Immunol. 11, 527-534. https://doi.org/10.1038/ni.1867
- Ciccia, F., Guggino, G., Rizzo, A., Manzo, A., Vitolo, B., La Manna, M.P., Giardina, G., Sireci, G., Dieli, F., Montecucco, C.M., et al. (2015). Potential involvement of IL-9 and Th9 cells in the pathogenesis of rheumatoid arthritis. Rheumatology (Oxford) 54, 2264-2272. https://doi.org/10.1093/rheumatology/kev252
- Conway, E.M., Pikor, L.A., Kung, S.H., Hamilton, M.J., Lam, S., Lam, W.L., and Bennewith, K.L. (2016). Macrophages, inflammation, and lung cancer. Am. J. Respir. Crit. Care Med. 193, 116-130. https://doi.org/10.1164/rccm.201508-1545CI
- Dantas, A.T., Marques, C.D., da Rocha Junior, L.F., Cavalcanti, M.B., Goncalves, S.M., Cardoso, P.R., Mariz Hde, A., Rego, M.J., Duarte, A.L., Pitta Ida, R., et al. (2015). Increased serum interleukin-9 levels in rheumatoid arthritis and systemic lupus erythematosus: pathogenic role or just an epiphenomenon? Dis. Markers 2015, 519638. https://doi.org/10.1155/2015/519638
- Dardalhon, V., Awasthi, A., Kwon, H., Galileos, G., Gao, W., Sobel, R.A., Mitsdoerffer, M., Strom, T.B., Elyaman, W., Ho, I.C., et al. (2008). IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells. Nat. Immunol. 9, 1347-1355. https://doi.org/10.1038/ni.1677
- Do Thi, V.A., Jeon, H.M., Park, S.M., Lee, H., and Kim, Y.S. (2019). Cell-based IL-15:IL-15Ralpha secreting vaccine as an effective therapy for CT26 colon cancer in mice. Mol. Cells 42, 869-883. https://doi.org/10.14348/molcells.2019.0188
- Do Thi, V.A., Park, S.M., Lee, H., and Kim, Y.S. (2016). The membranebound form of IL-17A promotes the growth and tumorigenicity of colon cancer cells. Mol. Cells 39, 536-542. https://doi.org/10.14348/molcells.2016.0048
- Do Thi, V.A., Park, S.M., Lee, H., and Kim, Y.S. (2018). Ectopically expressed membrane-bound form of IL-9 exerts immune-stimulatory effect on CT26 colon carcinoma cells. Immune Netw. 18, e12. https://doi.org/10.4110/in.2018.18.e12
- Edin, S., Wikberg, M.L., Dahlin, A.M., Rutegard, J., Oberg, A., Oldenborg, P.A., and Palmqvist, R. (2012). The distribution of macrophages with a M1 or M2 phenotype in relation to prognosis and the molecular characteristics of colorectal cancer. PLoS One 7, e47045. https://doi.org/10.1371/journal.pone.0047045
- Edin, S., Wikberg, M.L., Oldenborg, P.A., and Palmqvist, R. (2013). Macrophages: good guys in colorectal cancer. Oncoimmunology 2, e23038. https://doi.org/10.4161/onci.23038
- Fang, Y., Chen, X., Bai, Q., Qin, C., Mohamud, A.O., Zhu, Z., Ball, T.W., Ruth, C.M., Newcomer, D.R., Herrick, E.J., et al. (2015). IL-9 inhibits HTB-72 melanoma cell growth through upregulation of p21 and TRAIL. J. Surg. Oncol. 111, 969-974. https://doi.org/10.1002/jso.23930
- Goswami, R. and Kaplan, M.H. (2011). A brief history of IL-9. J. Immunol. 186, 3283-3288. https://doi.org/10.4049/jimmunol.1003049
- Hsieh, T.H., Hsu, C.Y., Tsai, C.F., Chiu, C.C., Liang, S.S., Wang, T.N., Kuo, P.L., Long, C.Y., and Tsai, E.M. (2016). A novel cell-penetrating peptide suppresses breast tumorigenesis by inhibiting beta-catenin/LEF-1 signaling. Sci. Rep. 6, 19156. https://doi.org/10.1038/srep19156
- Kaushik, N.K., Kaushik, N., Adhikari, M., Ghimire, B., Linh, N.N., Mishra, Y.K., Lee, S.J., and Choi, E.H. (2019). Preventing the solid cancer progression via release of anticancer-cytokines in co-culture with cold plasma-stimulated macrophages. Cancers (Basel) 11, e842. https://doi.org/10.3390/cancers11060842
- Kim, I.K., Kim, B.S., Koh, C.H., Seok, J.W., Park, J.S., Shin, K.S., Bae, E.A., Lee, G.E., Jeon, H., Cho, J., et al. (2015). Glucocorticoid-induced tumor necrosis factor receptor-related protein co-stimulation facilitates tumor regression by inducing IL-9-producing helper T cells. Nat. Med. 21, 1010-1017. https://doi.org/10.1038/nm.3922
- Lanier, L.L. (2003). Natural killer cell receptor signaling. Curr. Opin. Immunol. 15, 308-314. https://doi.org/10.1016/S0952-7915(03)00039-6
- Lee, J.E., Zhu, Z., Bai, Q., Brady, T.J., Xiao, H., Wakefield, M.R., and Fang, Y. (2019). The role of interleukin-9 in cancer. Pathol. Oncol. Res. 2019 Apr 23 [Epub]. https://doi.org/10.1007/s12253-019-00665-6.
- Li, H., Nourbakhsh, B., Cullimore, M., Zhang, G.X., and Rostami, A. (2011). IL-9 is important for T-cell activation and differentiation in autoimmune inflammation of the central nervous system. Eur. J. Immunol. 41, 2197-2206. https://doi.org/10.1002/eji.201041125
- Liu, M., Luo, F., Ding, C., Albeituni, S., Hu, X., Ma, Y., Cai, Y., McNally, L., Sanders, M.A., Jain, D., et al. (2015). Dectin-1 activation by a natural product beta-glucan converts immunosuppressive macrophages into an M1-like phenotype. J. Immunol. 195, 5055-5065. https://doi.org/10.4049/jimmunol.1501158
- Lu, Y., Hong, B., Li, H., Zheng, Y., Zhang, M., Wang, S., Qian, J., and Yi, Q. (2014a). Tumor-specific IL-9-producing CD8+ Tc9 cells are superior effector than type-I cytotoxic Tc1 cells for adoptive immunotherapy of cancers. Proc. Natl. Acad. Sci. U. S. A. 111, 2265-2270. https://doi.org/10.1073/pnas.1317431111
- Lu, Y., Hong, S., Li, H., Park, J., Hong, B., Wang, L., Zheng, Y., Liu, Z., Xu, J., He, J., et al. (2012). Th9 cells promote antitumor immune responses in vivo. J. Clin. Invest. 122, 4160-4171. https://doi.org/10.1172/JCI65459
- Lu, Y., Wang, Q., and Yi, Q. (2014b). Anticancer Tc9 cells: long-lived tumorkilling T cells for adoptive therapy. Oncoimmunology 3, e28542. https://doi.org/10.4161/onci.28542
- Ma, J., Liu, L., Che, G., Yu, N., Dai, F., and You, Z. (2010). The M1 form of tumor-associated macrophages in non-small cell lung cancer is positively associated with survival time. BMC Cancer 10, 112. https://doi.org/10.1186/1471-2407-10-112
- Malka, Y., Hornakova, T., Royer, Y., Knoops, L., Renauld, J.C., Constantinescu, S.N., and Henis, Y.I. (2008). Ligand-independent homomeric and heteromeric complexes between interleukin-2 or -9 receptor subunits and the gamma chain. J. Biol. Chem. 283, 33569-33577. https://doi.org/10.1074/jbc.M803125200
- Mantovani, A. and Sica, A. (2010). Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Curr. Opin. Immunol. 22, 231-237. https://doi.org/10.1016/j.coi.2010.01.009
- Mudter, J., Amoussina, L., Schenk, M., Yu, J., Brustle, A., Weigmann, B., Atreya, R., Wirtz, S., Becker, C., Hoffman, A., et al. (2008). The transcription factor IFN regulatory factor-4 controls experimental colitis in mice via T cell-derived IL-6. J. Clin. Invest. 118, 2415-2426. https://doi.org/10.1172/JCI33227
- Mukaida, N., Nosaka, T., Nakamoto, Y., and Baba, T. (2018). Lung macrophages: multifunctional regulator cells for metastatic cells. Int. J. Mol. Sci. 20, 116. https://doi.org/10.3390/ijms20010116
- Nalleweg, N., Chiriac, M.T., Podstawa, E., Lehmann, C., Rau, T.T., Atreya, R., Krauss, E., Hundorfean, G., Fichtner-Feigl, S., Hartmann, A., et al. (2015). IL-9 and its receptor are predominantly involved in the pathogenesis of UC. Gut 64, 743-755. https://doi.org/10.1136/gutjnl-2013-305947
- Orecchioni, M., Ghosheh, Y., Pramod, A.B., and Ley, K. (2019). Macrophage polarization: different gene signatures in M1(LPS+) vs. classically and M2(LPS-) vs. alternatively activated macrophages. Front. Immunol. 10, 1084. https://doi.org/10.3389/fimmu.2019.01084
- Steiger, S., Kuhn, S., Ronchese, F., and Harper, J.L. (2015). Monosodium urate crystals induce upregulation of NK1.1-dependent killing by macrophages and support tumor-resident NK1.1+ monocyte/macrophage populations in antitumor therapy. J. Immunol. 195, 5495-5502. https://doi.org/10.4049/jimmunol.1401755
- Tan, S.Y. and Krasnow, M.A. (2016). Developmental origin of lung macrophage diversity. Development 143, 1318-1327. https://doi.org/10.1242/dev.129122
- Wang, J., Sun, M., Zhao, H., Huang, Y., Li, D., Mao, D., Zhang, Z., Zhu, X., Dong, X., and Zhao, X. (2019). IL-9 exerts antitumor effects in colon cancer and transforms the tumor microenvironment in vivo. Technol. Cancer Res. Treat. 18, 1533033819857737.
- Xu, F., Cui, W.Q., Wei, Y., Cui, J., Qiu, J., Hu, L.L., Gong, W.Y., Dong, J.C., and Liu, B.J. (2018). Astragaloside IV inhibits lung cancer progression and metastasis by modulating macrophage polarization through AMPK signaling. J. Exp. Clin. Cancer Res. 37, 207. https://doi.org/10.1186/s13046-018-0878-0
- Ye, Z.J., Zhou, Q., Yin, W., Yuan, M.L., Yang, W.B., Xiong, X.Z., Zhang, J.C., and Shi, H.Z. (2012). Differentiation and immune regulation of IL-9-producing CD4+ T cells in malignant pleural effusion. Am. J. Respir. Crit. Care Med. 186, 1168-1179. https://doi.org/10.1164/rccm.201207-1307OC
- You, F.P., Zhang, J., Cui, T., Zhu, R., Lv, C.Q., Tang, H.T., and Sun, D.W. (2017). Th9 cells promote antitumor immunity via IL-9 and IL-21 and demonstrate atypical cytokine expression in breast cancer. Int. Immunopharmacol. 52, 163-167. https://doi.org/10.1016/j.intimp.2017.08.031
- Yuan, A., Hsiao, Y.J., Chen, H.Y., Chen, H.W., Ho, C.C., Chen, Y.Y., Liu, Y.C., Hong, T.H., Yu, S.L., Chen, J.J., et al. (2015). Opposite effects of M1 and M2 macrophage subtypes on lung cancer progression. Sci. Rep. 5, 14273. https://doi.org/10.1038/srep14273
피인용 문헌
- Crosstalk between the Producers and Immune Targets of IL-9 vol.20, pp.6, 2020, https://doi.org/10.4110/in.2020.20.e45
- Antibody-based delivery of interleukin-9 to neovascular structures: Therapeutic evaluation in cancer and arthritis vol.246, pp.8, 2020, https://doi.org/10.1177/1535370220981578
- Neural-Cadherin Influences the Homing of Terminally Differentiated Memory CD8 T Cells to the Lymph Nodes and Bone Marrow vol.44, pp.11, 2020, https://doi.org/10.14348/molcells.2021.0137